Palta Funding, Investors & Competitors

Palta has raised $124M across 4 funding rounds, most recently a $100M Series B in August 2021.

See full Palta profile

Last Palta funding round

$100M

Series B · Aug 2021

Cumulative funding Palta raised

$124M

across 4 funding rounds

Key investors in Palta

  • Target Global
  • VNV Global
  • Essential Capital
  • Zubr Capital
  • Stox Investments Limited

Palta Overview

About Palta

Palta is a Vilnius-headquartered health technology company developing consumer mobile applications for preventive care. Its portfolio includes Flo for menstrual cycle tracking, Simple for personalized nutrition plans, and Zing for habit coaching, serving millions of users worldwide.


Founded

2016

HQ

United KingdomLondon

Website

palta.com

Status

Privately held

Customer focus

B2C

Revenue model

Subscription, Advertising

Palta Funding History

Palta has raised a total of $124M across 4 funding rounds.

Palta's first fundraising round was a $10M Series A in January 2019. The most recent completed round was a $100M Series B in August 2021.

Palta funding rounds

Palta funding rounds
DateStageInvestorsRaisedDeal Summary
Aug 2021Series BVNV Global (lead); Essential Capital; Target Global; Zubr Capital$100MPalta is a London-based health and wellness technology company founded in 2016 by Alexey Gubarev and CEO Yuri Gurski, developing a suite of mobile subscription apps including Flo.Health (period and cycle-tracking), Simple Fasting, and Zing Fitness Coach, aimed at empowering health-aware consumers through its Palta Brain platform for rapid product scaling. The company completed a $100 million Series B funding round in August 2021 led by VNV Global (Per Brillioth), with participation from Target Global and other existing and new investors including Essential Capital, VNV Global, and Zubr Capital, to fuel product expansion and reach 1 billion users. At the time, Palta reported 2.4 million active paid subscribers across its apps, with most revenue derived from U.S. customers (60%) and Western Europe (20%), and claimed delivery of real-world results to over 100 million global consumers, alongside 10x growth in two years. VNV Global invested USD 7.7 million into Palta/Flo through Global Health Equity II as part of this larger round, highlighting Flo's over 40 million active users. The funding supports Palta's strategy of building a multi-product ecosystem in preventative health services, akin to top tech companies, by incubating internal ideas and investing in external health and fitness apps to address broader customer pain points and enable cross-pollination. Palta operates from offices in London, Munich, Vilnius, Warsaw, and other locations, positioning itself as a leader in mobile health with proven scaling capabilities.
Jul 2020Series ATarget Global (lead)$7M-
Jul 2019Series AStox Investments Limited (lead)$7M-
Jan 2019Series A-$10MPalta completed a Series A funding round on January 1, 2019, raising $14.1 million. No lead investor was specified for this round. The company later raised additional rounds, including a $24.9 million round in July 2020 and an $84.2 million (€84.2M) Series B in August 2021 led by VNV Global with participation from Target Global.

Who has invested in Palta?

5 investors have backed Palta across its funding rounds, including Target Global, VNV Global, Essential Capital, Zubr Capital and Stox Investments Limited.

Lead investors include VNV Global, Target Global and Stox Investments Limited.


Palta Investors

Investors in Palta by funding rounds participated
InvestorHQRoundsRoleFirst check
Target GlobalUnited KingdomLondon2LeadJul 2020
VNV GlobalSwedenStockholm1LeadAug 2021
Essential CapitalUnited StatesNew York City, NY1ParticipantAug 2021

This data is available for Pro users. Sign up to see all 5 Palta investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Investments by Palta

Palta has invested in 1 company to date.

Latest investment by Palta was on April 30th 2025. Palta invested in Pallie AI in their $2M Pre-seed round.


Latest Investments by Palta

Pallie AI
Description
Pallie AI is a developer of AI companions focused on mental health and daily wellbeing support. The app delivers personalized coaching via chat and voice interactions, tracking mood patterns and suggesting coping strategies based on CBT principles. Launched in 2023 from Helsinki, Pallie integrates with wearables for biometric insights and partners with therapists for escalated care. Available in 10 languages, it serves users in Europe and North America.
HQ CountryUnited States
HQ City
San Francisco, CA
Deal Date30 Apr 2025
RoundPre-seed
Raised$2M
InvestorsTrue Ventures
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Palta investments and their VC round multiples.

Start Free Trial

Palta Competitors

Palta competitors include listed companies like Compass Pathways and TALI Digital, and private ones like Workit Health, Slingshot AI, Midi Health and Neko Health.

Public and private companies comparable to Palta
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
Compass PathwaysUnited KingdomUnited KingdomPublicly listed-($293M)$2.1B-
Workit HealthUnited StatesAnn Arbor, MIPrivate--$500M-
Slingshot AIUnited StatesSan Francisco, CAPrivate$10M-$220M22.0x
TALI DigitalAustraliaAustraliaPublicly listed$166K($2M)$3M-
Midi HealthUnited StatesLos Angeles, CAPrivate$150M-$1B6.7x
Neko HealthSwedenStockholmPrivate--$7B-

Palta Public Comps

Palta is still privately-owned, but its public comps include Humana Inc., Hims, Doximity, ACADIA Pharmaceuticals, Compass Pathways, Alignment Healthcare, Teladoc, Helus Pharma, Talkspace and Sphere.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Humana Inc.$130B$3B0.4x0.3x17.8x16.6x
Hims$2.3B$178M3.1x2.4x40.4x23.9x
Doximity$645M$229M6.3x6.2x17.7x11.9x
ACADIA Pharmaceuticals$1.1B$119M3.6x3.2x32.3x33.6x
Compass Pathways-($293M)--(5.8x)(8.4x)
Alignment Healthcare$3.9B$45M0.4x0.3x31.6x10.0x
Teladoc$2.5B$124M0.6x0.6x11.3x5.0x
Helus Pharma-($153M)--(5.4x)(4.8x)

This data is available for Pro users. Sign up to see all Palta competitors and their valuation data.

Start Free Trial

Common questions about Palta

When was Palta founded?Palta was founded in 2016.
Where is Palta headquartered?Palta is headquartered in London, United Kingdom.
Is Palta publicly listed?No, Palta is a private, VC-backed company.
How much funding has Palta raised?Palta has raised $124M across 4 funding rounds.
What was Palta's last funding round?Palta's last funding round was a $100M Series B in August 2021, led by VNV Global.
Who are Palta's investors?Palta's investors include Target Global, VNV Global, Essential Capital, Zubr Capital and Stox Investments Limited.
Which companies are comparable to Palta?Companies comparable to Palta include Compass Pathways, Workit Health, Slingshot AI, TALI Digital, Midi Health and Neko Health.
How many companies has Palta invested in?Palta has invested in 1 company, including Pallie AI.
What was Palta's last investment?In April 2025, Palta invested in Pallie AI's $2M pre-seed round alongside True Ventures.

See companies similar to Palta

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial